{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:17:18Z","timestamp":1788671838046,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006247","name":"Anhui University of Science and Technology","doi-asserted-by":"publisher","award":["YZ2023H1A005"],"award-info":[{"award-number":["YZ2023H1A005"]}],"id":[{"id":"10.13039\/501100006247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020735","name":"Jiangxi Provincial Key Laboratory of Synthetic Chemistry","doi-asserted-by":"publisher","award":["HAP202303"],"award-info":[{"award-number":["HAP202303"]}],"id":[{"id":"10.13039\/100020735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["M2022046"],"award-info":[{"award-number":["M2022046"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.molimm.2026.08.012","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:27:56Z","timestamp":1787329676000},"page":"168-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PD-L1 upregulated by IGF1R via the PI3K\/AKT\/NF-\u03baB axis induces sorafenib resistance in hepatocellular carcinoma"],"prefix":"10.1016","volume":"198","author":[{"given":"Tao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2026.08.012_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 Expression by NF-\u03baB in Cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.012_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1423170","article-title":"PD-L1 expression is regulated by both DNA methylation and NF-\u03baB during EMT signaling in non-small cell lung carcinoma","volume":"7","author":"Asgarova","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12885-023-10561-7","article-title":"IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K\/AKT and RAS\/RAF\/ERK signaling pathways","volume":"23","author":"Cai","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib4","first-page":"8","article-title":"Cancer statistics 2024: all hands on deck","volume":"74","author":"Dizon","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"38","key":"10.1016\/j.molimm.2026.08.012_bib5","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"D'souza","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.molimm.2026.08.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117118","article-title":"Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: an update","volume":"177","author":"Fan","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molimm.2026.08.012_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/JHC.S285726","article-title":"Elucidating the molecular basis of sorafenib resistance in HCC: current findings and future directions","volume":"8","author":"Fornari","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.molimm.2026.08.012_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.acr.2020.10.002","article-title":"Signaling pathways in hepatocellular carcinoma","volume":"149","author":"Garcia-Lezana","year":"2021","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.molimm.2026.08.012_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4161\/cbt.2.6.678","article-title":"Mechanisms by which IGF-I may promote cancer","volume":"2","author":"Grimberg","year":"2003","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib11","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/JME-17-0311","article-title":"IGF1 receptor signaling pathways","volume":"61","author":"Hakuno","year":"2018","journal-title":"J. Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-020-00904-3","article-title":"Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy","volume":"13","author":"Hua","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.molimm.2026.08.012_bib13","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/biomedicines12071610","article-title":"The Role of the PI3K\/Akt\/mTOR Axis in Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Jiang","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.molimm.2026.08.012_bib14","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.7150\/thno.113347","article-title":"A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4","volume":"16","author":"Kim","year":"2026","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.molimm.2026.08.012_bib15","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1158\/0008-5472.CAN-21-2076","article-title":"Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality","volume":"82","author":"Kornepati","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2026.08.012_bib16","article-title":"Mutual connected IL-6, EGFR and LIN28\/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70025","article-title":"Chinese Visceral Adiposity Index Trajectory and Stroke in Prediabetes and Diabetes: A Prospective Cohort Study","volume":"41","author":"Liu","year":"2025","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40164-022-00297-8","article-title":"Current insight into the regulation of PD-L1 in cancer","volume":"11","author":"Liu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.012_bib19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/1878-0261.12664","article-title":"Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD-L1 and predicts poor prognosis in B-cell lymphoma","volume":"14","author":"Liu","year":"2020","journal-title":"Mol. Oncol."},{"issue":"14","key":"10.1016\/j.molimm.2026.08.012_bib20","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2174\/138945011798829401","article-title":"Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers","volume":"12","author":"Rowinsky","year":"2011","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.molimm.2026.08.012_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106222","article-title":"Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC)","volume":"81","author":"Shen","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.molimm.2026.08.012_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell."},{"issue":"3","key":"10.1016\/j.molimm.2026.08.012_bib23","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"37","key":"10.1016\/j.molimm.2026.08.012_bib24","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","article-title":"Biomarkers for the early diagnosis of hepatocellular carcinoma","volume":"21","author":"Tsuchiya","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.012_bib25","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.18632\/oncotarget.12123","article-title":"Type I insulin-like growth factor receptor signaling in hematological malignancies","volume":"8","author":"Vishwamitra","year":"2017","journal-title":"Oncotarget"},{"issue":"10360","key":"10.1016\/j.molimm.2026.08.012_bib26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.molimm.2026.08.012_bib27","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/cells11091553","article-title":"Insight into the Role of the PI3K\/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart","volume":"11","author":"Walkowski","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.molimm.2026.08.012_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.molimm.2026.08.012_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110639","article-title":"Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1\/Rad51 in gastric cancer","volume":"106","author":"Wang","year":"2023","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.molimm.2026.08.012_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2015.11.034","article-title":"MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS\/RAF\/ERK signaling pathways","volume":"371","author":"Xu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molimm.2026.08.012_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.802795","article-title":"PTRF\/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-\u03baB\/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma","volume":"12","author":"Yi","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.012_bib32","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s12072-024-10696-0","article-title":"CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R\/AKT\/SNAIL signaling pathway","volume":"18","author":"Zheng","year":"2024","journal-title":"Hepatol. Int."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:03:01Z","timestamp":1788670981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589026001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0161589026001926"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2026.08.012","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 upregulated by IGF1R via the PI3K\/AKT\/NF-\u03baB axis induces sorafenib resistance in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2026.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}